
View larger version (88K):
[in a new window]
|
Fig. 5. RNase treatment dissociates 53BP1 from the damage-induced foci. (A,B) NIH3T3 cells exposed to X rays were permeabilised with 0.5% Tween 20, treated with (B) or without (A) 1 mg/ml RNase A, fixed, and stained for 53BP1. The level of 53BP1 associated with the foci reduces significantly after treatment with RNase A. (C) Western blot for the samples treated with or without RNase A shows that this reduction is not due to degradation of 53BP1. Equal amounts of total protein were loaded in each lane. The blots for tubulin confirm equal loading. (D) Treatment with an endoribonuclease for RNA/DNA duplexes (RNase H) does not dissociate 53BP1 from the foci. (E,F) In contrast to 53BP1, phosphorylated -H2AX foci are not affected by RNase treatment. (G,H) X-irradiated HeLa cells were treated either with 0.5% Tween 20 alone (G) or with 0.5% Tween 20 plus RNase A (H). In the presence of 2% Tween 20 (I,J), 53BP1 was dissociated specifically by RNase A treatment (J). (K-Y), HeLa cells were transfected with plasmids expressing the GFP-M domain fusion or GFP- RG (M domain lacking the RG stretch). The cells were exposed to 10 Gy of X rays, incubated at 37°C for the period indicated (K-N, for 20 minutes; O-U, for 1 hour; V-Y, for 2 hours) and permeabilised with Tween 20. Cells were treated with (L,N,P,R,T,U,W,Y) or without (K,M,O,Q,V,X) RNase A after permeabilisation. (S) Cells were treated with RNase H. (T,U) After RNase A treatment, cells were treated with RNase inhibitor and then incubated with nuclear RNA (T) or with tRNA (U). Bars, 10 µm.
|